Literature DB >> 12196453

Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes.

Akihisa Imagawa, Tohru Funahashi, Tadashi Nakamura, Makoto Moriwaki, Sachiyo Tanaka, Hitoshi Nishizawa, Kouichi Sayama, Sae Uno, Hiromi Iwahashi, Kazuya Yamagata, Jun-Ichiro Miyagawa, Yuji Matsuzawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12196453     DOI： 10.2337/diacare.25.9.1665

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  34 in total

1.  Adiponectin dysregulation and insulin resistance in type 1 diabetes.

Authors:  Rocio I Pereira; Janet K Snell-Bergeon; Christopher Erickson; Irene E Schauer; Bryan C Bergman; Marian Rewers; David M Maahs
Journal:  J Clin Endocrinol Metab       Date:  2012-01-25       Impact factor: 5.958

2.  Determinants of undercarboxylated and carboxylated osteocalcin concentrations in type 1 diabetes.

Authors:  K M Thrailkill; C-H Jo; G E Cockrell; C S Moreau; C K Lumpkin; J L Fowlkes
Journal:  Osteoporos Int       Date:  2011-11-09       Impact factor: 4.507

3.  The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.

Authors:  T Costacou; J C Zgibor; R W Evans; J Otvos; M F Lopes-Virella; R P Tracy; T J Orchard
Journal:  Diabetologia       Date:  2004-12-23       Impact factor: 10.122

4.  Discovery and validation of serum protein changes in type 1 diabetes patients using high throughput two dimensional liquid chromatography-mass spectrometry and immunoassays.

Authors:  Wenbo Zhi; Ashok Sharma; Sharad Purohit; Eric Miller; Bruce Bode; Stephen W Anderson; John Chip Reed; R Dennis Steed; Leigh Steed; Diane Hopkins; Jin-Xiong She
Journal:  Mol Cell Proteomics       Date:  2011-09-06       Impact factor: 5.911

5.  Association of adiponectin, interleukin (IL)-1ra, inducible protein 10, IL-6 and number of islet autoantibodies with progression patterns of type 1 diabetes the first year after diagnosis.

Authors:  A Kaas; C Pfleger; L Hansen; K Buschard; N C Schloot; B O Roep; H B Mortensen
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

6.  Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications.

Authors:  J Frystyk; L Tarnow; T Krarup Hansen; H-H Parving; A Flyvbjerg
Journal:  Diabetologia       Date:  2005-08-03       Impact factor: 10.122

7.  Serum concentrations of adiponectin and resistin in hyperthyroid Graves' disease patients.

Authors:  L Sieminska; D Niedziolka; A Pillich; B Kos-Kudla; B Marek; M Nowak; H Borgiel-Marek
Journal:  J Endocrinol Invest       Date:  2008-09       Impact factor: 4.256

8.  Biomarkers of adiponectin: plasma protein variation and genomic DNA polymorphisms.

Authors:  Harvest F Gu
Journal:  Biomark Insights       Date:  2009-10-13

Review 9.  Adiponectin signaling in the liver.

Authors:  Terry P Combs; Errol B Marliss
Journal:  Rev Endocr Metab Disord       Date:  2014-06       Impact factor: 6.514

10.  A genome-wide association study reveals variants in ARL15 that influence adiponectin levels.

Authors:  J Brent Richards; Dawn Waterworth; Stephen O'Rahilly; Marie-France Hivert; Ruth J F Loos; John R B Perry; Toshiko Tanaka; Nicholas John Timpson; Robert K Semple; Nicole Soranzo; Kijoung Song; Nuno Rocha; Elin Grundberg; Josée Dupuis; Jose C Florez; Claudia Langenberg; Inga Prokopenko; Richa Saxena; Robert Sladek; Yurii Aulchenko; David Evans; Gerard Waeber; Jeanette Erdmann; Mary-Susan Burnett; Naveed Sattar; Joseph Devaney; Christina Willenborg; Aroon Hingorani; Jaquelin C M Witteman; Peter Vollenweider; Beate Glaser; Christian Hengstenberg; Luigi Ferrucci; David Melzer; Klaus Stark; John Deanfield; Janina Winogradow; Martina Grassl; Alistair S Hall; Josephine M Egan; John R Thompson; Sally L Ricketts; Inke R König; Wibke Reinhard; Scott Grundy; H-Erich Wichmann; Phil Barter; Robert Mahley; Y Antero Kesaniemi; Daniel J Rader; Muredach P Reilly; Stephen E Epstein; Alexandre F R Stewart; Cornelia M Van Duijn; Heribert Schunkert; Keith Burling; Panos Deloukas; Tomi Pastinen; Nilesh J Samani; Ruth McPherson; George Davey Smith; Timothy M Frayling; Nicholas J Wareham; James B Meigs; Vincent Mooser; Tim D Spector
Journal:  PLoS Genet       Date:  2009-12-11       Impact factor: 5.917
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.